UPDATE | April 4, 2025

Advanced CLD with S-CHOice®: higher productivity with transposase and ADCC with S-AfuCHO™

  • MAIL

Enhancing productivity and antibody-dependent cellular cytotoxicity (ADCC) activity is key to developing high-performing antibody therapeutics. With the right approach and technology, there’s no need to compromise. 


Our S-CHOice® and S-AfuCHO™ platforms are designed to optimize cell line performance, ensuring robust productivity while maintaining strong effector function.


Watch the webinar to learn how our advanced technologies can support your program. 


Enhancing productivity and antibody-dependent cellular cytotoxicity (ADCC) activity is key to developing high-performing antibody therapeutics. With the right approach and technology, there’s no need to compromise. 


Our S-CHOice® and S-AfuCHO™ platforms are designed to optimize cell line performance, ensuring robust productivity while maintaining strong effector function.


Watch the webinar to learn how our advanced technologies can support your program. 


  • CDO
  • CGMP
  • ADC
  • Bio Campus
  • IR
  • CMO

Share article

SITE MAP

close
Close

Your download is ready

Click Download.

Close

Subscribe to Our Newsletter

Please fill in your details, select one or more areas of interest, and click the subscribe button to receive our newsletter.

Subscribe to Our Newsletter
  • Interests
  • Privacy Policy to collect the email address that I have provided until I withdraw my consent. The collected information will only be used for the purpose of mailing service. If you do not wish to consent, you will not be able to receive the newsletter. Samsung Biologics respects the privacy of its subscribers.
Close

Please fill out the form
to view the full content

Please sign up to view the post..
* Required
Privacy Policy required